These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 352038)

  • 1. [Mitogenic activity of erythrogenic toxins. I. Type-specific inhibition of the mitogenic activity of erythrogenic toxins by antitoxic antisera from the rabbit (author's transl)].
    Petermann F; Knöll H; Köhler W
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):366-79. PubMed ID: 352038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mitogenic activity of erythrogenic toxins. II. Communication: determination of erythrogenic toxins in cultural supernatants of streptococcus pyogenes (author's transl)].
    Knöll H; Petermann F; Köhler W
    Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):466-73. PubMed ID: 358674
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).
    Braun MA; Gerlach D; Hartwig UF; Ozegowski JH; Romagné F; Carrel S; Köhler W; Fleischer B
    J Immunol; 1993 Mar; 150(6):2457-66. PubMed ID: 8450222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of erythrogenic toxins of Streptococcus pyogenes. VI. Mitogenic activity of isoelectrically focused erythrogenic toxin preparations and culture supernatants of group A streptococci.
    Knöll H; Gerlach D; Ozegowski JH; Hribalová V; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):49-60. PubMed ID: 6362280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies to erythrogenic toxin B in scarlatina patients].
    Silich VA; Fiks LI; Dodonov VN; Sezonova EP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):112-5. PubMed ID: 1092101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of erythrogenic toxins. IV. Communication: mitogenic activity of erythrogenic toxin produced by Streptococcus pyogenes strain NY-5.
    Knöll H; Hríbalová V; Gerlach D; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):15-26. PubMed ID: 7036595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation and characterization of erythrogenic toxins of Streptococcus pyogenes 3. communication: comparative studies of type A erythrogenic toxins (author's transl)].
    Gerlach D; Knöll H; Köhler W; Ozegowski JH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):277-86. PubMed ID: 6171120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrogenic toxin. II. The problem of antigenic heterogeneity of scarlet fever toxin. Neutralization tests].
    SCHUH V; JELINEK J
    Cesk Epidemiol Mikrobiol Imunol; 1960 Sep; 9():476-84. PubMed ID: 13748788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Purification and characterization of erythrogenic toxins. I. Investigation of erythrogenic toxin A produced by Streptococcus pyogenes strain NY-5 (author's transl)].
    Gerlach D; Knöll H; Köhler W
    Zentralbl Bakteriol A; 1980; 247(2):177-91. PubMed ID: 6775448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro lymphocytes stimulation with scarlet fever toxin.
    Trebichavský I; Hríbalová V; Pospísil M
    Folia Biol (Praha); 1979; 25(2):101-6. PubMed ID: 378718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Demonstration of cellular antibodies against streptococcal antigens in children (author's transl)].
    Knöll H; Knöll G; Köhler W
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):143-52. PubMed ID: 134534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of antitoxic immunity in patients with scarlatina according to passive hemagglutination reaction data].
    Silich VA; Fiks LI; Dodonov VN; Sezonova EP; Novik ZA
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):19-23. PubMed ID: 4590982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolation and characterization of erythrogenic toxins. VII. Study of the erythrogenic toxin type C produced by Streptococcus pyogenes].
    Ozegowski JH; Knöll H; Gerlach D; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):38-50. PubMed ID: 6431714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative experimental study of 3 depot preparations of scarlet fever erythrogenic toxin].
    KUSHKO IV; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():51-4. PubMed ID: 13755376
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor.
    Gerlach D; Knöll H; Köhler W; Ozegowski JH; Hríbalova V
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):221-33. PubMed ID: 6359775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigenic composition of preparations of purified erythrogenic toxin].
    Kazdobina IS; Akimova VV; Burshteĭn VA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):111-6. PubMed ID: 4975809
    [No Abstract]   [Full Text] [Related]  

  • 17. [A method for the quantitative estimation of antibodies to extracellular esterases produced by group A and B streptococci, and application to the sera of patients with scarlet fever (author's transl)].
    Hayano S; Tanaka A
    Kansenshogaku Zasshi; 1981 May; 55(5):339-45. PubMed ID: 6798138
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isolation and characterization of erythrogenic toxins. VIII. Purification of a biologically active protein of the molecular weight 10,000 (LMP-10k) from filtrates of Streptococcus pyogenes, strain NY-5. Relationship to erythrogenic toxin type A].
    Gerlach D; Ozegowski JH; Knöll H; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):75-84. PubMed ID: 3518295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic activity of purified streptococcal erythrogenic toxin on lymphocytes.
    Nauciel C
    Ann Immunol (Paris); 1973 Aug; 124(3):383-90. PubMed ID: 4589801
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue cages for study of experimental streptococcal infection in rabbits. I. Production of erythrogenic toxins in vivo.
    Knöll H; Holm SE; Gerlach D; Köhler W
    Immunobiology; 1982; 162(2):128-40. PubMed ID: 6811417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.